SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.

ABSTRACT:

Background

The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ("GRAVID").

Methods

The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pandemic, as well as to explore the effect of melanoma treatment and tumor stage on the risk of COVID-19 complications. These are the final data of the register, including cases from February 2020 to September 2021.

Results

One hundred-fifty cases were registered. Median age was 68 years (range 6-95), 61 (40%) patients were females, and 63 (42%) patients had stage IV. Thirty-nine (26%) were on treatment with immunotherapy, and 17 (11%) with BRAF-MEK inhibitors. COVID-19 was resolved in 119 cases, including 85 (57%) patients cu

SUBMITTER: Gonzalez-Cao M 

PROVIDER: S-EPMC9789885 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature